Opinion: Most-read First Opinion essays of 2022
The 22nd year of the 21st century, like most years before it, had its share…
Author: STAT
STAT+: Eric Lander’s next act: leading a nonprofit set on solving thorny scientific challenges
In January 2021, when President Biden tapped Eric Lander to serve as the White House…
Study could pave way for new antiviral, as China grapples with Covid wave
When Eric Xu fell sick and tested positive with Covid this month, he took pills…
STAT+: Drug companies set sights on new Covid medicines to boost depleted arsenal
It was not that long ago that the medical community had a small arsenal of…
U.S. imposes Covid testing requirements on travelers from China
The United States will require all travelers from China to show a negative Covid-19 test…
3 debates about addiction medicine to watch in 2023
The U.S. is experiencing its deadliest drug crisis ever, and there’s no end in sight….
STAT’s most memorable photos of 2022
Reflecting back on our favorite photographs from 2022, we are struck by how many portraits…
Opinion: How value-based payments to clinicians can help close equity gaps
The U.S. health system has been evolving over the past decade to focus on the…
STAT+: The FDA’s ‘breakthrough’ program for medical devices keeps gaining steam
For medical devices in the Breakthrough Devices Program, 2022 has been a breakout year. The…
Opinion: To effectively combat diabetes, policymakers must treat obesity like other diseases
Obesity is often included in the litany of chronic diseases that plague six in 10…
STAT+: Get ready for ‘the electric vehicles of biopharma’: Three biotech trends to watch in 2023
Predicting the future is famously a mug’s game. Between Covid-19, drug pricing legislation, and a…
Three years on, the pandemic — and our response — have been jolting. Here’s what even the experts didn’t see coming
People who study infectious diseases and who work in public health have long known a…
New FDA guidance explains that Plan B is not an abortion pill
The Food and Drug Administration on Friday altered the language attached to emergency contraceptive pills…
Flu activity in the U.S. continues to decline after early surge
Flu activity across the United States continues to decline, though it remains at high levels…
California medical school apologizes for unethical prisoner experiments
SAN FRANCISCO — A prominent California medical school has apologized for conducting dozens of unethical…
STAT+: Pharmalittle: FDA approves a Genentech blood-cancer drug; Sean Parker expands his immunotherapy research empire
Good morning, Pharmalittle family! Your loyal scribe Ed Silverman is taking today off, so he…
Opinion: Allowing pharmacies to dispense methadone is dangerous for patients and communities
Congress is expected to pass a massive $1.7 trillion omnibus spending package that includes numerous…
STAT+: Parker Institute extends ‘crazy idea’ funding to two more cancer centers
With his Parker Institute for Cancer Immunotherapy, Sean Parker has been building a dream team…
STAT+: ‘Apples to apples’: How new health data rules could hold providers accountable
Last year, medical records opened up to patients. This year, they’re opening up to the…
.jpg)
STAT+: Apple Watch hit with import ban, but ruling remains suspended as AliveCor patent battle plays out
In the latest twist in a battle between Apple and medical device company AliveCor, the…
2022 in review, CEO indictments, & the year ahead
When does optimism become criminal? Why can’t biotech find its way back? And what’s going…
U.S. life expectancy falls for second straight year as drug overdose and Covid deaths take toll
Life expectancy for Americans fell for the second straight year in 2021, largely driven by…
After nine months, an update on NIH’s long Covid research
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Eisai and Biogen’s latest Alzheimer’s drug needs to be cheaper than the last one, analysts say
The latest Alzheimer’s disease treatment from Eisai and Biogen needs to be cheaper than $20,000…
STAT+: Pharmalittle: Merck pays Chinese biotech $175 million for cancer drugs; who will make a gene therapy for very sick kids?
Good morning everyone! Matthew Herper is here, filling in for Pharmalot, who is taking a…
Pandemic response gets a permanent new home at the White House
WASHINGTON — The era of the rotating cast of public health czars at the White House…
Opinion: Lessons learned from the deadly combination of sepsis and Covid-19
Sepsis, a deadly overreaction of the immune system to infection, has befuddled clinicians and researchers…
Under new rules, methadone clinics can offer more take-home doses. Will they?
Danielle Russell is, as she says, a “poster child” for methadone. For more than a…
STAT+: Backed by a longtime mental health leader, a new startup aims to build support for serious mental illness
The number of startups focused on mental health has surged in the wake of the…
STAT+: Former MIT professor tried to influence investigation of harassment at lab, report states
Former Massachusetts Institute of Technology professor David Sabatini attempted to influence a legal investigation into…
Gene therapy trial shows promise for treating ‘bubble boy’ syndrome. Now comes the hard part
H.T. Begay is a happy kid. He’s smiley, silly, and definitely trying to make you…
In a first, children with rare genetic diseases get mitochondrial transplants from their mothers
At a far distant point in Earth’s ancient past, two separate, single-celled life forms —…
STAT+: California wants to revoke a CVS mail-order license for illegally filling opioid and ADHD prescriptions
California authorities are seeking to revoke a license held by a CVS Health mail-order pharmacy…
STAT+: Young private equity firm Catalio to absorb hedge fund HealthCor, capping off busy year of investment M&A
Two veterans of the health care investing world — Art Cohen and Joe Healey —…
STAT+: Medicare’s home hospital program may soon get a lifeline from Congress. Can it prove its worth?
A Medicare program that allowed approved health systems to bill for hospital care delivered in…
STAT+: Pharmalittle: ICER cuts cost-effective price for Pfizer Covid pill; McDonald’s sets targets to reduce antibiotic use in cattle
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
Infectious disease board recommends hospitals stop screening asymptomatic patients for Covid-19
An influential board of infectious disease physicians recommended Wednesday that hospitals and other health care…
Opinion: Specialized centers can help realign the U.S.’s moral compass for sickle cell disease
Even as the United States has made commitments to health as a human right and…
Every kick, a reminder: in post-Roe California, a painful wait before ending a wanted pregnancy
This is part of a series of snapshots from post-Roe America. He loved peaches. He…
Why EPA’s long-awaited proposal on two ‘forever chemicals’ is bound to be controversial
By the end of this year, the Environmental Protection Agency has promised to propose new…
STAT+: Biden admin shares ownership data for thousands of hospitals, improving transparency about private equity’s stake
Citing its commitment to transparency and promoting competition, the Biden administration on Tuesday released a…
STAT+: McDonald’s adds targets for limiting antibiotic use in beef to its menu, but doesn’t say when
After being accused of backtracking on a commitment to reduce its use of medically important…
CytoDyn’s former CEO indicted for securities fraud. His misleading statements hurt patients even more than investors
Beginning in 2018 and through 2021, CytoDyn and its former CEO Nadir Pourhassan told investors…
Diabetes treatments are improving. Racial disparities are wider than ever
Despite advancements in insulin treatments over the past three decades, disparities in outcomes have widened…
CVS, Walgreens limiting purchases of children’s drugs amid cold and flu season shortages
Caring for sick children has become extra stressful recently for many U.S. parents due to…
STAT+: Pharmalittle: Pharma wins changes in bill concerning accelerated approval; pharmacy chains restrict purchases of pediatric pain relievers
Rise and shine, everyone, another busy day is on the way. And we can tell…
STAT+: Kite to buy Tmunity Therapeutics, Carl June’s troubled CAR-T startup
Kite Pharma, Gilead’s cell therapy subsidiary, said on Tuesday it would buy Tmunity, a biotech…
Opinion: Reducing the threat of vaccine-preventable diseases starts with kids
Americans have been warned — again — about lax attention to routine vaccinations. This time…
Amid dire maternal mortality rates, Congress falls short on Medicaid postpartum care
Last week, the state of Texas issued a long-awaited report that found at least 118…
‘One needs to feel safe’: Racism can put sleep — and its health benefits — out of reach
Lots of people struggle to get enough sleep — and the responsibility for fixing the…